Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Rhea-AI Summary

Guardant Health, a leader in precision oncology, announced its participation in the UBS Genomics 2.0 and MedTech Innovations Summit on August 10 at 4:00 p.m. PT. The event will feature a fireside chat with the company’s management, accessible via a webcast on their website. Guardant Health specializes in revolutionary cancer testing technologies like Guardant360 and Guardant Reveal, aimed at improving clinical outcomes and reducing costs. Their innovations support comprehensive cancer care and screening programs to help combat cancer globally.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.

Guardant Health’s management is scheduled to participate in a fireside chat on Tuesday, August 10 at 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360^®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI^® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210806005507/en/

FAQ

What is Guardant Health's participation in the UBS Summit on August 10, 2023?

Guardant Health will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on August 10, 2023.

What time is Guardant Health's presentation at the UBS Summit?

Guardant Health's presentation is scheduled for August 10, 2023, at 4:00 p.m. Pacific Time.

Where can I watch the webcast of Guardant Health's UBS Summit presentation?

The webcast of Guardant Health's presentation can be accessed in the 'Investors' section of their website.

What technologies does Guardant Health focus on for cancer treatment?

Guardant Health specializes in precision oncology technologies like Guardant360 and Guardant Reveal for cancer diagnosis and monitoring.

How does Guardant Health aim to improve patient outcomes?

Guardant Health uses advanced tests and analytics to enhance patient clinical outcomes and lower healthcare costs.